Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05602454 · ClinicalTrials.gov registry record · NA

Virtual Care to Improve Heart Failure Outcomes (VITAL-HF)

A NA study of Heart Failure With Reduced Ejection Fraction, sponsored by Duke University.

Completed
Registry status
NA
Development phase
178
Enrollment target
7
Study locations

NCT05602454 is a NA study of Heart Failure With Reduced Ejection Fraction that has completed, run by Duke University. The registered enrollment target is 178 participants, below the 3,959-participant average among 27 other Heart Failure With Reduced Ejection Fraction trials with a reported enrollment target (96% lower). The trial reports 7 study locations across 7 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05602454, a NA study of Heart Failure With Reduced Ejection Fraction, has completed, sponsored by Duke University.

COMPLETED
Registry status
NA
Development phase
178 participants
Enrollment target
7
Study locations

Study Summary

The purpose of this study is to evaluate how safe and effective a remote, digital intervention is that helps clinicians use and optimally adjust heart failure medications, compared to usual care medication use and adjustment, in participants with heart failure with reduced ejection fraction

Interventions

  • OTHER Digital Heart Failure Medication Titration

Study Locations (7)

Florida

  • Cardiovascular Institute of Northwest Florida - Panama City

Indiana

  • Ascension St. Vincent - Indianapolis

Kansas

  • The University of Kansas Medical Center - Kansas City

Minnesota

  • Minneapolis Heart Institute Foundation - Minneapolis

Missouri

  • Saint Luke's Health Systems - Kansas City

North Carolina

  • Duke University - Durham

Ohio

  • Cleveland Clinic - Cleveland

Trial Details

FieldValue
Enrollment Target 178 participants
Start Date 2022-12-02
Est. Completion 2025-03-05
Phase NA

Sponsor

Duke University

1,725 total trials

What the Registry Record Tells You About NCT05602454

The ClinicalTrials.gov registry entry for NCT05602454 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 178 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,959-participant average among 27 other Heart Failure With Reduced Ejection Fraction trials with a reported enrollment target (96% lower). The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Heart Failure With Reduced Ejection Fraction appearing as the primary indexed condition, and to 1 intervention - of which Digital Heart Failure Medication Titration is the first listed.

NCT05602454 reports 7 study locations spanning 7 distinct geographic areas - top geographies include Florida, Indiana, Kansas.

Frequently Asked Questions

What is clinical trial NCT05602454 about?

NCT05602454 is a clinical study titled "Virtual Care to Improve Heart Failure Outcomes (VITAL-HF)". The purpose of this study is to evaluate how safe and effective a remote, digital intervention is that helps clinicians use and optimally adjust heart failure medications, compared to usual care medication use and adjustment, in participants with heart failure with reduced ejection fraction

What is the current status of trial NCT05602454?

This trial is currently completed. It is a NA study. The enrollment target is 178 participants. The study started on 2022-12-02. Estimated completion is 2025-03-05.

What conditions does trial NCT05602454 study?

This clinical trial studies the following conditions: Heart Failure With Reduced Ejection Fraction.

What interventions are being tested in trial NCT05602454?

The interventions under investigation include: Digital Heart Failure Medication Titration (OTHER).

Who is sponsoring clinical trial NCT05602454?

This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05602454 being conducted?

This trial has 7 study locations across Florida, Indiana, Kansas, Minnesota, Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Heart Failure With Reduced Ejection Fraction

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.